Daniel E Spratt Selected Research

Radiotherapy

5/2024	Reply by Authors - Major Complications and Adverse Events Related to use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy.
4/2024	Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis.
3/2024	Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
3/2024	Major Complications and Adverse Events Related to Use of SpaceOAR Hydrogel for Prostate Cancer Radiotherapy.
12/2023	Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials.
12/2023	Re: Dose-escalated Radiotherapy Alone or in Combination with Short-term Androgen Deprivation for Intermediate-risk Prostate Cancer: Results of a Phase III Multi-institutional Trial.
12/2023	Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption.
11/2023	Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.
10/2023	Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients: Incidence and Success Rate of Peer-To-Peer Authorization in Allowing Patients to Remain Trial-Eligible.
10/2023	Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel E Spratt Research Topics

Disease

220	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 03/2013
97	Neoplasms (Cancer) 10/2023 - 04/2010
55	Neoplasm Metastasis (Metastasis) 10/2023 - 03/2013
8	Disease Progression 10/2023 - 06/2015
7	Adenocarcinoma 12/2023 - 11/2016
6	Pain (Aches) 01/2023 - 10/2019
5	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2010
5	Glioblastoma (Glioblastoma Multiforme) 10/2020 - 01/2014
5	Carcinoma (Carcinomatosis) 01/2020 - 10/2017
4	Margins of Excision 01/2023 - 11/2016
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 10/2016
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2016
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 12/2019
3	COVID-19 12/2020 - 07/2020
3	Oropharyngeal Neoplasms 03/2016 - 01/2012
2	Hypertension (High Blood Pressure) 03/2024 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2016
2	Tuberous Sclerosis (Bourneville's Disease) 05/2020 - 07/2019
2	Spinal Cord Compression 11/2019 - 01/2018
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2019 - 01/2018
2	Teratoma (Teratoid Tumor) 01/2018 - 07/2017
2	Lymphoma (Lymphomas) 01/2017 - 02/2016
1	Atrial Fibrillation 03/2024
1	Headache (Headaches) 03/2024
1	Kidney Neoplasms (Kidney Cancer) 09/2023
1	Small Cell Carcinoma 01/2023
1	Neuroendocrine Carcinoma 01/2023
1	Infections 01/2022
1	Wound Infection (Wound Infections) 01/2022
1	Contracture 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022

Drug/Important Bio-Agent (IBA)

59	AndrogensIBA 04/2024 - 03/2013
38	Prostate-Specific Antigen (Semenogelase)IBA 05/2024 - 03/2013
28	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2012
25	Androgen Receptors (Androgen Receptor)IBA 04/2024 - 11/2013
22	Hormones (Hormone)IBA 04/2024 - 04/2015
13	AntigensIBA 01/2023 - 05/2014
11	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2017
7	enzalutamideIBA 12/2023 - 01/2017
7	Docetaxel (Taxotere)FDA Link 01/2023 - 01/2019
6	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2010
5	Phenobarbital (Luminal)FDA Link 10/2023 - 12/2017
4	abirateroneIBA 02/2023 - 01/2019
4	bicalutamide (Casodex)FDA LinkGeneric 01/2022 - 01/2017
3	HydrogelsIBA 05/2024 - 01/2023
3	relugolixIBA 03/2024 - 01/2022
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2024 - 01/2018
3	Testosterone (Sustanon)FDA Link 01/2022 - 01/2018
3	LigandsIBA 01/2022 - 10/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 11/2017
3	Androgen Antagonists (Antiandrogens)IBA 10/2020 - 11/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2012
3	Metformin (Glucophage)FDA LinkGeneric 03/2016 - 04/2013
2	InterferonsIBA 02/2023 - 01/2023
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2019
2	ChromatinIBA 02/2021 - 02/2016
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2020 - 07/2019
2	PlatinumIBA 11/2019 - 09/2014
2	Phosphotransferases (Kinase)IBA 07/2019 - 01/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 01/2014
2	B7-H1 AntigenIBA 10/2018 - 10/2017
2	Radioisotopes (Radionuclides)IBA 11/2017 - 01/2014
2	Estrogen ReceptorsIBA 01/2017 - 04/2015
2	antineoplaston A10 (A 10)IBA 01/2017 - 08/2016
2	J591 monoclonal antibodyIBA 12/2016 - 05/2014
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2014 - 06/2010
1	apalutamideIBA 04/2024
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 03/2024
1	Leuprolide (Lupron)FDA LinkGeneric 03/2024
1	Poly Adenosine Diphosphate RiboseIBA 12/2023
1	Prednisone (Sone)FDA LinkGeneric 09/2023
1	Abiraterone AcetateIBA 09/2023
1	Moclobemide (Arima)IBA 05/2023
1	AlbuminsIBA 01/2023
1	PSMA-617IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Lutetium-177IBA 01/2023
1	mesoglycanIBA 01/2022
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2022
1	gallium 68 PSMA-11IBA 01/2022

Therapy/Procedure

151	Radiotherapy 05/2024 - 04/2010
114	Therapeutics 04/2024 - 01/2011
42	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 05/2014
27	Castration 03/2024 - 04/2013
16	Brachytherapy 01/2023 - 09/2013
12	Drug Therapy (Chemotherapy) 01/2023 - 06/2010
5	Salvage Therapy 10/2023 - 04/2020
4	Immunotherapy 01/2019 - 01/2017
3	Palliative Care (Palliative Therapy) 12/2019 - 01/2018
3	Adjuvant Radiotherapy 10/2018 - 06/2016
2	Length of Stay 01/2022 - 10/2019
2	Decompression 01/2021 - 10/2019
2	Precision Medicine 12/2020 - 01/2019
2	Orchiectomy (Orchidectomy) 05/2019 - 01/2018
2	Cystectomy 01/2019 - 10/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 10/2016
2	Combined Modality Therapy 01/2017 - 03/2016
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 03/2014 - 06/2013
1	Injections 01/2022